Dystonia is a neurological disorder characterized by involuntary muscle contractions that cause the body to move into abnormal posture or position. It can occur in people of all ages, though it is more common in young children and adults in their 20s to 40s. Dystonic disorders are a result of a disruption in the balance between opposing muscle groups, typically leading to sustained and involuntary contractions of those muscle groups. These contractions lead to abnormal body movements such as muscle spasms, twisting of certain body parts, and difficulty in speaking and walking. The exact cause of dystonic disorders is unknown, although research has identified a number of possible contributing factors, including genetic and environmental factors. It is thought that there may be an imbalance in the brain's neurotransmitters – the chemicals responsible for communication between brain cells – which can lead to abnormal brain function and, in turn, dystonia. Some people may also have a pre-existing susceptibility to the disorder, which can make them more likely to develop it. Dystonic disorders can be divided into two main categories, primary and secondary. Primary dystonias are those for which no clear cause can be identified, while secondary dystonias are those resulting from a known cause, such as head trauma, stroke, or a toxin exposure. Primary dystonia can be further divided into generalized dystonia (involving most of the body), focal dystonia (involving just one body part), and segmental dystonia (involving two or more body parts). Depending on the type of dystonia, its symptoms can range from mild to severe and may include difficulty speaking, walking, or swallowing; gait disturbances; muscle pain or stiffness; tremor; difficulty breathing; and fatigue. Treatment of dystonic disorders will depend on the type and severity of the disorder, but may involve physical therapy, medications, or, in severe cases, surgical procedures such as deep brain stimulation or botulinum toxin injections.
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : ADNP regulates cortical development: Mechanism of ADNP syndrome/autism
Kazuhito Toyooka, Drexel University College of Medicine, United States
Title : Mild cognitive impairment (MCI) in Parkinson’s disease: Prevalence given MDS criteria
Cay Anderson Hanley, iPACES, United States
Title : Modeling early neurologic trajectories after elevated leg positioning (ELP): A secondary analysis of the LEG-UP randomized feasibility study
Kayode Ahmed, The University of Texas MD Anderson Cancer Center, United States
Title : Neuro-exergaming for non-verbal autism spectrum: A case study of neuropsychological function after 15 sessions of pedal-n-play iPACES
Cay Anderson Hanley, iPACES, United States
Title : Prescribing joy: The importance of integrating memory cafes into dementia care
Saul Beaumont, Massachusetts Advisory Council on Alzheimer's Disease and All Other Dementias, United States